Director, Global Regulatory Lead (GRL)
Apellis Pharmaceuticals
This listing was originally posted on Apellis Pharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moOpportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases.
Summary:
The Director, Global Regulatory Lead (GRL) is accountable for developing and executing innovative, integrated global regulatory strategies for assigned assets from development through approval and lifecycle management. Serving as the primary regulatory strategic partner to cross-functional development and governance teams, the Director translates scientific, clinical, safety, CMC, labeling, operational, and business priorities into clear regulatory plans and decisions. This role leads through a global matrix, aligns requirements across major health authorities—including the FDA, EMA, PMDA, ANVISA, and CDE)—anticipates and mitigates complex regulatory risks, and represents the company with regulatory authorities, contractors, and corporate partners. The Director independently drives key regulatory decisions and escalates material issues and recommendations to senior leadership and governance bodies as appropriate.Roles and Responsibilities:
Qualifications
Required Experience: Prior experience as a regional or global regulatory lead, ideally with direct responsibility for US and/or EU strategy.
Work Arrangement:
HybridTravel Requirements:
10% travelEducation:
PharmDBenefits and Perks:
Apellis offers a comprehensive benefits package, inclusive flexible time off, summer and winter shutdowns, paid family leave and more!
Company Background:
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
For more information, please visit http://apellis.com or follow us on LinkedIn and X.
Other Duties:
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Apellis Pharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Cyclic peptide analog
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo